Oncology Flashcards

1
Q

large number of V, D, J and C segments can be transcribed and translated to millions of antigen receptors

A

DNA recombination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

lymphocytesInvolved in the process of antigen recognition by normal B and T cells

Structurally similar: heterodimer proteins liked by disulfide bonds; composed of variable (V) and constant (C) regions

Genetically similar: consist of a large number of exons DNA recombination to functional receptor

A

Surface Immunoglobulin and T-cell Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Gene rearrangements are normal events that occur in ________

A

lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Light chain does NOT have ___ segment

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

To detect cell ‘clonality’

A

Uses consensus V and J segment primers (recognize shared DNA sequences)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Monoclonal population are detected by ____ _____ unique to the tumor

A

sharp bands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A family of apoptosis-regulating proteins (preventing apoptosis)

A

BCL 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cyclin D1

A

BCL 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Originate in epithelial tissue, such as the cells lining the intestine, bronchi, or mammary ducts

A

Carcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The tumor has arisen in mesenchymal tissue, such as bone muscle or connective tissue, or in nervous system tissue

A

Sarcomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Spread throughout the bone marrow, lymphatic system, and peripheral blood

A

Hematopoietic and lymphoid malignant neoplasms, such as leukemia and lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

______ mutation are needed for tumor formation

A

Multiple

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

______ affected organs (such as in breast cancer)

A

Bilaterally - hereditary cancer characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A large nuclear phosphoprotein

Expression and phosphorylation is cell cycle dependent

Probably a DNA-binding transcription factor and also involved in DNA repair

A

The BRCA1 protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Localized to chromosome arm 17q

120 different mutations have been identified

A

BRCA 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

gene include 23 exons, and a large exon 11 (100 kb) that contains 60% of the coding sequence

A

BRCA 1

17
Q

Mutated in 45% of hereditary breast cancers and 90% of patients with breast/ovarian cancer

A

BRCA 1

18
Q

Localized to chromosome arm 13q

Accounts for approximately 40-45% of early onset hereditary breast cancer

A

BRCA 2

19
Q

A tumor-suppressor gene of 70 kb in size, containing 27 exons

required to prevent the breakdown of stalled replication forks

Disruption of this function leads to chromosomal rearrangements

May cause genomic instability and predisposition to cancer

A

BRCA 2

20
Q

Mutation does not contribute significantly to risk for development of ovarian cancer

A

BRCA 2

21
Q

185delAG

5382insC

A

BRCA 1 in the Ashkenazi Jewish Community

22
Q

6174 del T

A

BRCA 2 in the Ashkenazi Jewish Community

23
Q

MSI

A

microsatellite instability protein

24
Q

MSI
KRAS
BRAF

A

Molecular CRC (colorectal) markers

25
Q

____ ______ is the third most common non-skin cancer diagnosed in men and women in the US.

A

Colorectal cancer

26
Q

PCR (paraffin works well)

MMR immunohistochemistry: MLH-1, MSH-2, MSH-6, PMS-2

Blood germline mutation analysis

Deleted affected family members

A

Detect affected pts with tumor MSI by:

27
Q

KRAS mutations in 30-____ _____

A

40% CRCs

28
Q

85-90% of all lung cancers are_____

A

NSCLC (non-small cell lung cancer)